OnCore Login

Return to Trial Database

LUN13-175

A Phase I/II Study of Carboplatin/Nab-Paclitaxel and MK-3475 for Advanced Non-Small Cell Lung Cancer (NSCLC): LUN13-175

 

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

Ph I/II Carboplatin, Nab-Paclitaxel and Pembrolizumab for Advanced NSCLC
  • R Gentzler, N Mohindra, S Jalal, K Reckamp, R Hall, N. Hanna, YK Chae, V Villaflor, M Koczywas, I Helenowski, A Rademaker, J Patel
Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non–Small Cell Lung Cancer
  • R Gentzler, N Mohindra, S Jalal, K Reckamp, R Hall, N Hanna, YK Chae, M Koczywas, I Helenowski, J Patel

Trial Locations

All sites in which the trial LUN13-175 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278